ncsm-20230731x8k
false000169242700016924272023-07-312023-07-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

July 31, 2023

Date of Report (Date of earliest event reported)

NCS Multistage Holdings, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

001-38071

46-1527455

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification Number)

19350 State Highway 249, Suite 600

Houston, Texas 77070

(Address of principal executive offices) (Zip code)

(281) 453-2222

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

NCSM

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 2.02Results of Operations and Financial Condition.

On July 31, 2023, NCS Multistage Holdings, Inc. (the “Company”) issued a press release announcing its results for the quarter ended June 30, 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in this Item 2.02 and the accompanying exhibit is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this Item 2.02 and the accompanying exhibit shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.

Item 9.01Financial Statements and Exhibits.

 

(d)

 

Exhibits.

Exhibit

Number

Description of the Exhibit

99.1

Press Release dated July 31, 2023.

104

Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 31, 2023

NCS Multistage Holdings, Inc.

By:  

/s/ Michael Morrison

Michael Morrison

Chief Financial Officer

2023 Q2 Exhibit 991

Exhibit 99.1

 





 

Picture 1

NCS Multistage Holdings, Inc. 

19350 State Highway 249, Suite 600

Houston, Texas 77070



PRESS RELEASE



NCS MULTISTAGE HOLDINGS, INC. ANNOUNCES SECOND QUARTER 2023 RESULTS



Second Quarter Results



·

Total revenues of $25.4 million, an 8% year-over-year decrease

·

Net loss of $(32.2) million and loss per share of $(13.02), compared to a net loss of $(5.5) million and a loss per share of $(2.25) in the same quarter of 2022

·

Adjusted net loss of $(6.2) million and adjusted loss per share of $(2.50), compared to an adjusted net loss of $(5.1) million and adjusted loss per share of $(2.09)

·

Adjusted EBITDA of $(2.2) million, a decrease of $(0.3) million from the second quarter of 2022

·

$13.7 million in cash and $8.8 million of total debt as of June 30, 2023



HOUSTON, July 31, 2023 – NCS Multistage Holdings, Inc. (Nasdaq: NCSM) (the “Company,” “NCS,” “we” or “us”), a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies, today announced its results for the quarter ended June 30, 2023.



Financial Review



Total revenues were $25.4 million for the quarter ended June 30, 2023, which was a decrease of 8% compared to the second quarter of 2022.  This decrease reflects lower U.S. product sales and services revenues and lower international services revenues, offset by increases in Canadian product sales and services revenues. Despite the average rig counts remaining relatively stable for the quarters ending June 30, 2023 and 2022, and some favorable pricing for our offerings, the sales of our products in the United States were particularly affected by lower commodity prices, especially natural gas, which had a negative impact on customer activity levels. Improved sales in Canada for the same period were tempered by the effect of the Canadian wildfires in 2023. 



Compared to the first quarter of 2023, total revenues decreased by 42%, with decreases of 53% and 17% in Canada and the United States, primarily related to the normal seasonal decline in Canada during the second quarter due to the spring break-up, and, to a lesser extent, a declining rig count and lower commodity pricing in the United States, which contributed to a decline in activity levels for some of our customers during the quarter. These sequential revenue decreases were partially offset by an increase of 8% in the international markets.



Gross profit, defined as total revenues less total cost of sales exclusive of depreciation and amortization, for the second quarter of 2023 was $8.5 million, or 33% of total revenues, compared to $8.9 million, or 33% of total revenues, for the second quarter of 2022.  While we experienced a decline in our revenues, we maintained our gross profit percentage primarily due to improved pricing for our products and services. This pricing improvement was offset by lower product sales volumes, ongoing inflationary pressures, leading to increased operating costs, and certain expenses associated with consolidations undertaken in June 2023 of our tracer diagnostics business operations and Repeat Precision’s manufacturing operations in Mexico.



Despite the declines in our second quarter and sequential revenues, our revenues for the first half of 2023 of $68.9 million increased by 4% compared to the first half of 2022 primarily due to higher product sales in Canada. Also, our gross profit percentage for the first half of 2023 improved to 39%, up from 36% for the same period one year ago.

 

Selling, general and administrative (“SG&A”) expenses totaled $14.5 million for the second quarter of 2023, an increase of $0.7 million compared to the same period in 2022. This increase in expense reflects higher compensation and benefit costs primarily associated with salary increases implemented during the first quarter of 2023 and increased headcount, as well as a severance charge associated with our consolidation efforts noted above and an increase in software expense. These increases were partially offset by lower professional fees.



 

1

 


 

 

Net loss was $(32.2) million, or $(13.02) per share, for the quarter ended June 30, 2023.  Our net loss for the second quarter of 2023 was significantly impacted by a $24.9 million incremental provision related to our ongoing litigation matters. We believe that established case law supports a strong ground to appeal the rendered judgment in the Texas matter, which is more fully described in our Quarterly Report on Form 10-Q  for the period ended June 30, 2023, and we expect a large portion, up to all, of the awarded damages to be covered by insurance. In accordance with U.S. GAAP, we have not recorded any benefit that may be realized upon appeal of this judgment nor any anticipated insurance recoveries, and such benefits or recoveries will be recorded in the period received or deemed realizable.



Our adjusted net loss was $(6.2) million, or $(2.50) per diluted share, which primarily adjusts for the litigation provision, net of tax, as noted above. For the quarter ended June 30, 2022,  our adjusted net loss was $(5.1) million, or $(2.09) per share.



Adjusted EBITDA was $(2.2) million for the quarter ended June 30, 2023, a decrease of $(0.3) million compared to the same period a year ago. This decrease is the result of lower revenues compared to the second quarter of 2022. Our Adjusted EBITDA for the six months ended June 30, 2023 was $2.6 million, an improvement of $2.3 million compared to the $0.3 million Adjusted EBITDA for the same period last year.



Cash flow from operating activities for the six months ended June 30,  2023 was a use of $1.0 million, a $4.2 million improvement compared to cash used for the comparable period in 2022. Cash flow used in investing activities of $1.0 million for 2023 compares to $0.3 million for 2022. For the six months ended June 30, 2023, free cash flow was a use of cash of $2.0 million compared to a use of cash of $5.5 million for the same period in 2022. The overall improvement in net cash flows was largely attributed to our operating results, net of the provision for litigation, and the change in our net working capital.



Liquidity and Capital Expenditures



As of June 30, 2023, NCS had $13.7 million in cash and $8.8 million in total debt, and the borrowing base under our undrawn asset-based revolving credit facility (“ABL Facility”) totaled $12.6 million. Our net working capital, defined as current assets excluding cash and cash equivalents, minus current liabilities excluding current maturities of long-term debt, was $55.7 million and $55.2 million as of June 30, 2023 and December 31, 2022, respectively.



NCS incurred capital expenditures, net of proceeds from the sale of property and equipment, of $1.0 million and $0.3 million for the six months ended June 30, 2023 and 2022, respectively.



Review and Outlook



NCS’s Chief Executive Officer, Ryan Hummer commented, “Our performance in Canada was the highlight for NCS in the second quarter. Canadian revenues increased by 11% as compared to the second quarter of 2022, outperforming the increase in the average rig count during the same period of only 4%. This demonstrates the success of our efforts to penetrate customers that remain active throughout spring break-up and the impact of our continued efforts to achieve pricing that reflects the value that we bring to our customers.



Unfortunately, this was more than offset by challenges faced in the U.S., where revenues declined by 17% compared to the first quarter of 2023 and by 23% compared to the second quarter of 2022. The sequential revenue decline in the U.S. reflected the impact of falling industry drilling and completion activity and affected all NCS product lines, except for Repeat Precision, where revenues improved by 13% sequentially. International revenues of $1.7 million were a slight improvement from the first quarter of 2023, but lower than the second quarter of 2022. We made progress during the quarter to enable future revenue opportunities in the Middle East and added to our growing customer base in the North Sea.



Our total revenues of $25.4 million in the second quarter of 2023 was 8% below total revenues in the second quarter of 2022, though our total revenues through the first six months of 2023 of $68.9 million was 4% higher than the year-ago period.



Our second quarter gross margin percentage of 33% was in line with the second quarter of 2022, despite lower revenues, and increased to 39% for the first half of 2023 as compared to 36% for the first half of 2022. The favorable gross margin percentage primarily reflects initiatives to improve our pricing over the last two years.



We continuously assess opportunities to streamline our operations and improve profitability. We initiated efforts in June 2023 to consolidate certain operations and facilities for our tracer diagnostics product line and also consolidated Repeat Precision’s manufacturing footprint in Mexico into a single facility. We expect to start recognizing the full benefit of these consolidation efforts in the fourth quarter of 2023, with an expected annualized benefit of over $1.5 million on a consolidated basis.



On our previously disclosed legal matter in Texas, we are disappointed with the judgment rendered against us that awarded the plaintiffs damages of $42.5 million, inclusive of interest. While we have increased our legal provision to reflect the total judgment, less amounts previously paid by our insurance carrier to the plaintiff, we believe that we have a  strong ground to appeal this judgment,

2


 

 

which we do not believe applies the proper measure of damages in Texas. We intend to appeal the judgment and believe we have strong arguments that may lead to a reversal of some or all the awarded damages. In addition, we continue to believe a large portion, up to all, of any remaining damages upon appeal will be covered by our insurance carrier.



Given the rapid decline in the U.S. rig count thus far in 2023 and potential impact on activity resulting from production curtailments related to wildfires in Canada which have impacted customer cash flows, we have reduced our expectations for customer activity for 2023. We currently expect 2023 annual average industry drilling and completion activity in the United States to be 5% -10% below 2022 levels and annual average drilling and completion activity in Canada to be up to 5% higher than in 2022. Despite the lower rig count in the United States, we expect sequential improvements in revenues for each of our Canadian, U.S., and international operations during the third quarter of 2023.



I am encouraged about the opportunities for NCS in 2023 and beyond as we deliver on our long-term strategies to build upon our leading market positions, capitalize on opportunities in international and offshore markets and as we bring new and innovative solutions to our customers around the world.



I want to express my gratitude to the team at NCS and at Repeat Precision – it is through the expertise, dedication and ingenuity of our outstanding people that we can deliver extraordinary outcomes to our customers, drive innovation in the industry and create value for our shareholders.”



Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted (Loss) Earnings per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital are non-GAAP financial measures. For an explanation of these measures and a reconciliation, refer to “Non-GAAP Financial Measures” below.



Conference Call



The Company will host a conference call to discuss its second quarter 2023 results and updated guidance on Tuesday,  August 1, 2023 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). The conference call will be available via a live audio webcast. Participants who wish to ask questions may register for the call here to receive the dial-in numbers and unique PIN. If you wish to join the conference call but do not plan to ask questions, you may join the listen-only webcast here. The live webcast can also be accessed by visiting the Investors section of the Company’s website at ir.ncsmultistage.com. It is recommended that participants join at least 10 minutes prior to the event start.



The replay will be available in the Investors section of the Company’s website shortly after the conclusion of the call and will remain available for approximately seven days.



About NCS Multistage Holdings, Inc.



NCS Multistage Holdings, Inc. is a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides products and services primarily to exploration and production companies for use in onshore and offshore wells, predominantly wells that have been drilled with horizontal laterals in both unconventional and conventional oil and natural gas formations. NCS’s products and services are utilized in oil and natural gas basins throughout North America and in selected international markets, including Argentina, China, the Middle East and the North Sea.  NCS’s common stock is traded on the Nasdaq Capital Market under the symbol “NCSM.” Additional information is available on the website, www.ncsmultistage.com.



3


 

 

Forward Looking Statements



This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods, or by the inclusion of forecasts or projections. Examples of forward-looking statements include, but are not limited to, statements we make regarding the outlook for our future business and financial performance and insurance coverage and appellate prospects for litigation matters. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause our actual results to differ materially from those in the forward-looking statements include regional, national or global political, economic, business, competitive, market and regulatory conditions and the following: declines in the level of oil and natural gas exploration and production activity in Canada, the United States and internationally; oil and natural gas price fluctuations; significant competition for our products and services that results in pricing pressures, reduced sales, or reduced market share; our inability to successfully develop and implement new technologies, products and services that align with the needs of our customers, including addressing the shift to more non-traditional energy markets as part of the energy transition; inability to successfully implement our strategy of increasing sales of products and services into the U.S. and international markets; loss of significant customers; our inability to protect and maintain critical intellectual property assets; losses and liabilities from uninsured or underinsured business activities and litigation; our failure to identify and consummate potential acquisitions; our inability to integrate or realize the expected benefits from acquisitions; loss of any of our key suppliers or significant disruptions negatively impacting our supply chain; our inability to achieve suitable price increases to offset the impacts of cost inflation; risks in attracting and retaining qualified employees and key personnel or related to labor cost inflation; risks resulting from the operations of our joint venture arrangement; currency exchange rate fluctuations; uncertainties relating to the recent bank failures and Federal Deposit Insurance Corporation response; impact of severe weather conditions and the Canadian wildfires; restrictions on the availability of our customers to obtain water essential to the drilling and hydraulic fracturing processes; changes in legislation or regulation governing the oil and natural gas industry, including restrictions on emissions of greenhouse gases; our inability to meet regulatory requirements for use of certain chemicals by our tracer diagnostics business; change in trade policy, including the impact of tariffs; our inability to accurately predict customer demand, which may result in us holding excess or obsolete inventory; failure to comply with or changes to federal, state and local and non-U.S. laws and other regulations, including anti-corruption and environmental regulations, guidelines and regulations for the use of explosives; the financial health of our customers including their ability to pay for products or services provided; loss of our information and computer systems; system interruptions or failures, including complications with our enterprise resource planning system, cyber-security breaches, identity theft or other disruptions that could compromise our information; impairment in the carrying value of long-lived assets including goodwill; our failure to establish and maintain effective internal control over financial reporting; the reduction in our ABL Facility borrowing base or our inability to comply with the covenants in our debt agreements; and our inability to obtain sufficient liquidity on reasonable terms, or at all and other factors discussed or referenced in our filings made from time to time with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release speaks only as of the date on which we make it. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.



Contact

Michael Morrison

Chief Financial Officer

(281) 453-2222

IR@ncsmultistage.com 

4


 

 

NCS MULTISTAGE HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)







 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2023

 

2022

 

2023

 

2022

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

$

17,433 

 

$

19,371 

 

$

48,863 

 

$

45,584 

Services

 

 

7,958 

 

 

8,093 

 

 

20,082 

 

 

20,992 

Total revenues

 

 

25,391 

 

 

27,464 

 

 

68,945 

 

 

66,576 

Cost of sales

 

 

 

 

 

 

 

 

 

 

 

 

Cost of product sales, exclusive of depreciation
    and amortization expense shown below

 

 

11,994 

 

 

13,399 

 

 

30,827 

 

 

31,156 

Cost of services, exclusive of depreciation
    and amortization expense shown below

 

 

4,935 

 

 

5,124 

 

 

11,115 

 

 

11,570 

Total cost of sales, exclusive of depreciation
    and amortization expense shown below

 

 

16,929 

 

 

18,523 

 

 

41,942 

 

 

42,726 

Selling, general and administrative expenses

 

 

14,477 

 

 

13,745 

 

 

30,628 

 

 

29,769 

Depreciation

 

 

948 

 

 

939 

 

 

1,891 

 

 

1,860 

Amortization

 

 

167 

 

 

167 

 

 

334 

 

 

334 

Loss from operations

 

 

(7,130)

 

 

(5,910)

 

 

(5,850)

 

 

(8,113)

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(211)

 

 

(407)

 

 

(420)

 

 

(590)

Provision for litigation

 

 

(24,886)

 

 

 —

 

 

(42,400)

 

 

 —

Other income, net

 

 

1,478 

 

 

613 

 

 

1,770 

 

 

992 

Foreign currency exchange gain (loss), net

 

 

23 

 

 

(255)

 

 

78 

 

 

Total other (expense) income

 

 

(23,596)

 

 

(49)

 

 

(40,972)

 

 

403 

Loss before income tax

 

 

(30,726)

 

 

(5,959)

 

 

(46,822)

 

 

(7,710)

Income tax expense (benefit)

 

 

1,350 

 

 

(481)

 

 

250 

 

 

(503)

Net loss

 

 

(32,076)

 

 

(5,478)

 

 

(47,072)

 

 

(7,207)

Net income (loss) attributable to non-controlling interest

 

 

155 

 

 

 

 

128 

 

 

(191)

Net loss attributable to
    NCS Multistage Holdings, Inc.

 

$

(32,231)

 

$

(5,481)

 

$

(47,200)

 

$

(7,016)

Loss per common share

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per common share attributable to
    NCS Multistage Holdings, Inc.

 

$

(13.02)

 

$

(2.25)

 

$

(19.16)

 

$

(2.89)

Diluted loss per common share attributable to
    NCS Multistage Holdings, Inc.

 

$

(13.02)

 

$

(2.25)

 

$

(19.16)

 

$

(2.89)

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

2,476 

 

 

2,438 

 

 

2,464 

 

 

2,426 

Diluted

 

 

2,476 

 

 

2,438 

 

 

2,464 

 

 

2,426 

















5


 

 

NCS MULTISTAGE HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS*

(In thousands, except share data)

(Unaudited)









 

 

 

 

 

 



 

June 30,

 

December 31,



 

2023

 

2022

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

13,746 

 

$

16,234 

Accounts receivable—trade, net

 

 

22,169 

 

 

27,846 

Inventories, net

 

 

42,788 

 

 

37,042 

Prepaid expenses and other current assets

 

 

2,918 

 

 

2,815 

Other current receivables

 

 

3,682 

 

 

3,726 

Total current assets

 

 

85,303 

 

 

87,663 

Noncurrent assets

 

 

 

 

 

 

Property and equipment, net

 

 

24,106 

 

 

23,316 

Goodwill

 

 

15,222 

 

 

15,222 

Identifiable intangibles, net

 

 

4,741 

 

 

5,076 

Operating lease assets

 

 

5,552 

 

 

4,515 

Deposits and other assets

 

 

2,217 

 

 

2,761 

Deferred income taxes, net

 

 

334 

 

 

46 

Total noncurrent assets

 

 

52,172 

 

 

50,936 

Total assets

 

$

137,475 

 

$

138,599 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable—trade

 

$

7,855 

 

$

7,549 

Accrued expenses

 

 

4,423 

 

 

4,391 

Income taxes payable

 

 

314 

 

 

468 

Operating lease liabilities

 

 

1,578 

 

 

1,274 

Current maturities of long-term debt

 

 

2,350 

 

 

1,489 

Other current liabilities

 

 

1,670 

 

 

2,522 

Total current liabilities

 

 

18,190 

 

 

17,693 

Noncurrent liabilities

 

 

 

 

 

 

Long-term debt, less current maturities

 

 

6,404 

 

 

6,437 

Operating lease liabilities, long-term

 

 

4,571 

 

 

3,680 

Accrual for legal contingencies

 

 

42,400 

 

 

 —

Other long-term liabilities

 

 

1,258 

 

 

1,328 

Deferred income taxes, net

 

 

426 

 

 

199 

Total noncurrent liabilities

 

 

55,059 

 

 

11,644 

Total liabilities

 

 

73,249 

 

 

29,337 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

Preferred stock, $0.01 par value, 10,000,000 shares authorized, no shares issued and outstanding at

 

 

 

 

 

 

June 30, 2023 and December 31, 2022

 

 

 —

 

 

 —

Common stock, $0.01 par value, 11,250,000 shares authorized, 2,476,298 shares issued

 

 

 

 

 

 

and 2,438,877 shares outstanding at June 30, 2023 and 2,434,809 shares issued

 

 

 

 

 

 

and 2,408,474 shares outstanding at December 31, 2022

 

 

25 

 

 

24 

Additional paid-in capital

 

 

442,431 

 

 

440,475 

Accumulated other comprehensive loss

 

 

(85,274)

 

 

(85,617)

Retained deficit

 

 

(309,664)

 

 

(262,464)

Treasury stock, at cost, 37,421 shares at June 30, 2023 and 26,335 shares

 

 

 

 

 

 

at December 31, 2022

 

 

(1,653)

 

 

(1,389)

Total stockholders' equity

 

 

45,865 

 

 

91,029 

Non-controlling interest

 

 

18,361 

 

 

18,233 

Total equity

 

 

64,226 

 

 

109,262 

Total liabilities and stockholders' equity

 

$

137,475 

 

$

138,599 

_____________________

*

Preliminary

6


 

 

NCS MULTISTAGE HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)











 

 

 

 

 

 



 

Six Months Ended



 

June 30,



 

2023

 

2022

Cash flows from operating activities

 

 

 

Net loss

 

$

(47,072)

 

$

(7,207)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

2,225 

 

 

2,194 

Amortization of deferred loan costs

 

 

102 

 

 

128 

Write-off of deferred loan costs

 

 

 —

 

 

196 

Share-based compensation

 

 

2,542 

 

 

3,485 

Provision for inventory obsolescence

 

 

245 

 

 

1,294 

Deferred income tax expense

 

 

57 

 

 

59 

Gain on sale of property and equipment

 

 

(333)

 

 

(222)

Provision for credit losses

 

 

58 

 

 

(44)

Provision for litigation

 

 

42,400 

 

 

 —

Proceeds from note receivable

 

 

271 

 

 

282 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable—trade

 

 

6,474 

 

 

3,878 

Inventories, net

 

 

(5,907)

 

 

(4,876)

Prepaid expenses and other assets

 

 

552 

 

 

1,271 

Accounts payable—trade

 

 

(196)

 

 

499 

Accrued expenses

 

 

(4)

 

 

(2,767)

Other liabilities

 

 

(2,331)

 

 

(2,591)

Income taxes receivable/payable

 

 

(125)

 

 

(777)

Net cash used in operating activities

 

 

(1,042)

 

 

(5,198)

Cash flows from investing activities

 

 

 

 

 

 

Purchases of property and equipment

 

 

(1,151)

 

 

(420)

Purchase and development of software and technology

 

 

(167)

 

 

(56)

Proceeds from sales of property and equipment

 

 

340 

 

 

175 

Net cash used in investing activities

 

 

(978)

 

 

(301)

Cash flows from financing activities

 

 

 

 

 

 

Payments on finance leases

 

 

(743)

 

 

(712)

Line of credit borrowings

 

 

8,397 

 

 

7,543 

Payments of line of credit borrowings

 

 

(7,663)

 

 

(7,096)

Treasury shares withheld

 

 

(264)

 

 

(380)

Payment of deferred loan cost related to ABL facility

 

 

 —

 

 

(880)

Net cash used in financing activities

 

 

(273)

 

 

(1,525)

Effect of exchange rate changes on cash and cash equivalents

 

 

(195)

 

 

(214)

Net change in cash and cash equivalents

 

 

(2,488)

 

 

(7,238)

Cash and cash equivalents beginning of period

 

 

16,234 

 

 

22,168 

Cash and cash equivalents end of period

 

$

13,746 

 

$

14,930 

Noncash investing and financing activities

 

 

 

 

 

 

Assets obtained in exchange for new finance lease liabilities

 

$

845 

 

$

864 

Assets obtained in exchange for new operating lease liabilities

 

$

1,789 

 

$

819 

 

7


 

 

NCS MULTISTAGE HOLDINGS, INC.

REVENUES BY GEOGRAPHIC AREA

(In thousands)

(Unaudited)







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2023

 

2022

 

2023

 

2022

United States

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

$

6,942 

 

$

9,173 

 

$

15,002 

 

$

16,334 

Services

 

 

2,440 

 

 

2,960 

 

 

5,699 

 

 

4,877 

Total United States

 

 

9,382 

 

 

12,133 

 

 

20,701 

 

 

21,211 

Canada

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

 

9,970 

 

 

9,655 

 

 

32,531 

 

 

28,707 

Services

 

 

4,351 

 

 

3,193 

 

 

12,461 

 

 

12,670 

Total Canada

 

 

14,321 

 

 

12,848 

 

 

44,992 

 

 

41,377 

Other Countries

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

 

521 

 

 

543 

 

 

1,330 

 

 

543 

Services

 

 

1,167 

 

 

1,940 

 

 

1,922 

 

 

3,445 

Total Other Countries

 

 

1,688 

 

 

2,483 

 

 

3,252 

 

 

3,988 

Total

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

 

17,433 

 

 

19,371 

 

 

48,863 

 

 

45,584 

Services

 

 

7,958 

 

 

8,093 

 

 

20,082 

 

 

20,992 

Total revenues

 

$

25,391 

 

$

27,464 

 

$

68,945 

 

$

66,576 

 

8


 

 



NCS MULTISTAGE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION

(In thousands, except per share data)  

(Unaudited)



Non-GAAP Financial Measures 



EBITDA is defined as net (loss) income before interest expense, net, income tax expense and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted to exclude certain items which we believe are not reflective of ongoing operating performance or which, in the case of share-based compensation, is non-cash in nature. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of total revenues. Adjusted EBITDA Less Share-Based Compensation is defined as Adjusted EBITDA minus share-based compensation expense. Adjusted Net (Loss) Income is defined as net (loss) income attributable to NCS Multistage Holdings, Inc. adjusted to exclude certain items which we believe are not reflective of ongoing performance. Adjusted (Loss) Earnings per Diluted Share is defined as Adjusted Net (Loss) Income divided by our diluted weighted average common shares outstanding during the relevant period. Free cash flow is defined as net cash (used in) provided by operating activities less purchases of property and equipment (inclusive of the purchase and development of software and technology) plus proceeds from sales of property and equipment, as presented in our consolidated statements of cash flows. We define free cash flow less distributions to non-controlling interest as free cash flow less distributions to non-controlling interest, as presented in the net cash used in financing activities section of our consolidated statements of cash flows. Net working capital is defined as total current assets, excluding cash and cash equivalents, minus total current liabilities, excluding current maturities of long-term debt. Net working capital excludes cash and cash equivalents and current maturities of long-term debt in order to evaluate the investment in working capital required to support our business. We believe that Adjusted EBITDA, Adjusted Net (Loss) Income and Adjusted (Loss) Earnings per Diluted Share are important measures that exclude costs that management believes do not reflect our ongoing operating performance and, in the case of Adjusted EBITDA, certain costs associated with our capital structure. We believe that Adjusted EBITDA Less Share-Based Compensation presents our financial performance in a manner that is comparable to the presentation provided by many of our peers. We believe free cash flow is useful because it provides information to investors regarding the cash that was available in the period that was in excess of our needs to fund our capital expenditures and other investment needs. We believe that free cash flow less distributions to non-controlling interest is useful because it provides information to investors regarding the cash that was available in the period that was in excess of our needs to fund our capital expenditures, other investment needs, and cash distributions to our joint venture partner. We believe that net working capital is useful in analyzing the cash flow and working capital needs of the Company, including determining the efficiencies of our operations and our ability to readily convert assets into cash. Accordingly, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted (Loss) Earnings per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital are key metrics that management uses to assess the period-to-period performance of our core business operations. We believe that presenting these metrics enables investors to assess our performance from period to period using the same metrics utilized by management and to evaluate our performance relative to other companies that are not subject to such factors.



EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EBITDA Less Share-Based Compensation, Adjusted Net (Loss) Income, Adjusted (Loss) Earnings per Diluted Share, Free Cash Flow, Free Cash Flow Less Distributions to Non-Controlling Interest and net working capital (our “non-GAAP financial measures”) are not defined under generally accepted accounting principles (“GAAP”), are not measures of net (loss) income, (loss) income from operations, cash (used in) provided by operating activities, working capital or any other performance measure derived in accordance with GAAP, and are subject to important limitations. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies in our industry and are not measures of performance calculated in accordance with GAAP. Our non-GAAP financial measures have important limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our financial performance as reported under GAAP, and they should not be considered as alternatives to net (loss) income, (loss) income from operations, cash (used in) provided by operating activities, working capital or any other performance measures derived in accordance with GAAP as measures of operating performance or as alternatives to cash flow from operating activities as measures of our liquidity.



The tables below set forth reconciliations of our non-GAAP financial measures to the most directly comparable measures of financial performance calculated under GAAP:



NET WORKING CAPITAL*





 

 

 

 

 

 



 

June 30,

 

December 31,



 

2023

 

2022

Working capital

 

$

67,113 

 

$

69,970 

Cash and cash equivalents

 

 

(13,746)

 

 

(16,234)

Current maturities of long term debt

 

 

2,350 

 

 

1,489 

Net working capital

 

$

55,717 

 

$

55,225 

_____________________

*

Preliminary



9


 

 

NCS MULTISTAGE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION

(In thousands, except per share data)  

(Unaudited)



ADJUSTED NET LOSS AND ADJUSTED LOSS PER DILUTED SHARE





___



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30, 2023

 

June 30, 2022

 

June 30, 2023

 

June 30, 2022



 

Effect on
Net Loss

 

Impact on Diluted Loss Per Share

 

Effect on
Net Loss

 

Impact on Diluted Loss Per Share

 

Effect on
Net Loss

 

Impact on Diluted Loss Per Share

 

Effect on
Net Loss

 

Impact on Diluted Loss Per Share

Net loss attributable to NCS Multistage Holdings, Inc.

 

$

(32,231)

 

$

(13.02)

 

$

(5,481)

 

$

(2.25)

 

$

(47,200)

 

$

(19.16)

 

$

(7,016)

 

$

(2.89)

Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for litigation (a)

 

 

24,886 

 

 

10.05 

 

 

 —

 

 

 —

 

 

42,400 

 

 

17.21 

 

 

 —

 

 

 —

Foreign currency exchange (gain) loss (b)

 

 

(48)

 

 

(0.02)

 

 

232 

 

 

0.09 

 

 

(105)

 

 

(0.04)

 

 

(17)

 

 

(0.01)

Write-off of deferred loan

costs (c)

 

 

 —

 

 

 —

 

 

196 

 

 

0.08 

 

 

 —

 

 

 —

 

 

196 

 

 

0.08 

Income tax impact from adjustments (d)

 

 

1,197 

 

 

0.49 

 

 

(32)

 

 

(0.01)

 

 

288 

 

 

0.12 

 

 

(15)

 

 

 —

Adjusted net loss attributable to

   NCS Multistage Holdings, Inc.

 

$

(6,196)

 

$

(2.50)

 

$

(5,085)

 

$

(2.09)

 

$

(4,617)

 

$

(1.87)

 

$

(6,852)

 

$

(2.82)

__________________

(a)

Represents litigation provision associated with certain litigation matters. We intend to appeal the judgment awarded in Texas and believe we have strong arguments that may lead to a reversal of some or all the awarded damages. Even though we expect a large portion, up to all, of the awarded damages to be covered by insurance, other than amounts previously paid by the insurance carrier to the plaintiff, we have not recognized an asset or an offsetting benefit as of June  30, 2023. Any insurance proceeds will be recorded as an offset to this provision in the period received or deemed to be realizable.

(b)

Represents realized and unrealized foreign currency translation gains and losses attributable to NCS Multistage Holdings, Inc. primarily due to movement in the foreign currency exchange rates during the applicable periods.

(c)

Represents deferred loan costs of $0.2 million expensed during the second quarter of 2022 associated with the prior credit facility replaced in May 2022.

(d)

Represents income tax impacts based on applicable effective tax rates. The 2022 amounts were changed from prior presentation to exclude the effect of valuation allowance adjustments.

10


 

 

NCS MULTISTAGE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION

(In thousands)

(Unaudited)



ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ADJUSTED EBITDA LESS SHARE-BASED COMPENSATION







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2023

 

2022

 

2023

 

2022

Net loss

 

$

(32,076)

 

$

(5,478)

 

$

(47,072)

 

$

(7,207)

Income tax expense (benefit)

 

 

1,350 

 

 

(481)

 

 

250 

 

 

(503)

Interest expense, net

 

 

211 

 

 

407 

 

 

420 

 

 

590 

Depreciation

 

 

948 

 

 

939 

 

 

1,891 

 

 

1,860 

Amortization

 

 

167 

 

 

167 

 

 

334 

 

 

334 

EBITDA

 

 

(29,400)

 

 

(4,446)

 

 

(44,177)

 

 

(4,926)

Provision for litigation (a)

 

 

24,886 

 

 

 —

 

 

42,400 

 

 

 —

Share-based compensation (b)

 

 

1,044 

 

 

841 

 

 

1,957 

 

 

1,646 

Professional fees (c)

 

 

577 

 

 

1,078 

 

 

1,661 

 

 

3,145 

Foreign currency exchange (gain) loss (d)

 

 

(23)

 

 

255 

 

 

(78)

 

 

(1)

Severance and other termination benefits (e)

 

 

309 

 

 

 —

 

 

309 

 

 

 —

Other (f)

 

 

362 

 

 

277 

 

 

553 

 

 

422 

Adjusted EBITDA

 

$

(2,245)

 

$

(1,995)

 

$

2,625 

 

$

286 

Adjusted EBITDA Margin

 

 

(9)%

 

 

(7%)

 

 

4% 

 

 

0% 

Adjusted EBITDA Less Share-Based Compensation

 

$

(3,289)

 

$

(2,836)

 

$

668 

 

$

(1,360)

___________________

(a)

Represents litigation provision associated with certain litigation matters.  We intend to appeal the judgment awarded in Texas and believe we have strong arguments that may lead to a reversal of some or all the awarded damages. Even though we expect a large portion, up to all, of the awarded damages to be covered by insurance, other than amounts previously paid by the insurance carrier to the plaintiff, we have not recognized an asset or an offsetting benefit as of June 30, 2023. Any insurance proceeds will be recorded as an offset to this provision in the period received or deemed to be realizable.

(b)

Represents non-cash compensation charges related to share-based compensation granted to our officers, employees and directors.

(c)

Represents non-capitalizable costs of professional services primarily incurred in connection with our legal proceedings.

(d)

Represents realized and unrealized foreign currency translation gains and losses primarily due to movement in the foreign currency exchange rates during the applicable periods.

(e)

Represents certain expenses associated with consolidations of our tracer diagnostics business operations and Repeat Precision’s manufacturing operations in Mexico.

(f)

Represents the impact of a research and development subsidy that is included in income tax expense in accordance with GAAP along with other charges and credits.



FREE CASH FLOW AND FREE CASH FLOW LESS DISTRIBUTIONS TO NON-CONTROLLING INTEREST







 

 

 

 

 

 



 

Six Months Ended



 

June 30,



 

2023

 

2022

Net cash used in operating activities

 

$

(1,042)

 

$

(5,198)

Purchases of property and equipment

 

 

(1,151)

 

 

(420)

Purchase and development of software and technology

 

 

(167)

 

 

(56)

Proceeds from sales of property and equipment

 

 

340 

 

 

175 

Free cash flow

 

$

(2,020)

 

$

(5,499)

Distributions to non-controlling interest

 

 

 —

 

 

 —

Free cash flow less distributions to non-controlling interest

 

$

(2,020)

 

$

(5,499)

























11